Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | HCAR3 | P49019 | 8/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL106249 | 1.00 | CASP6 (0.72) | CASP6TSHRLMNAHCAR3MAPK1 | |
| SCHEMBL1898142 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3MAPK1 | |
| SCHEMBL9469176 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3MAPK1 | |
| Hydrochloric Acid SCHEMBL10607831 | 0.96 | CASP6 (0.68) | CASP6TSHRLMNAHCAR3MAPK1 | |
| Benzoic Acid SCHEMBL28359564 | 0.93 | CASP6 (0.64) | CASP6TSHRLMNAHCAR3MAPK1 | |
| SCHEMBL7103159 | 0.86 | VCAM1 (0.65) | CASP6TSHRLMNAMAPK1ALDH1A1 | |
| SCHEMBL2156599 | 0.86 | MAPK1 (0.60) | CASP6TSHRLMNAMAPK1ALDH1A1 | |
| SCHEMBL4340852 | 0.86 | ERN1 (0.61) | CASP6TSHRLMNAMAPK1ALDH1A1 | |
| SCHEMBL9660912 | 0.85 | GPR35 (0.55) | CASP6TSHRLMNAHCAR3MAPK1 | |
| SCHEMBL459609 | 0.85 | CASP6 (0.72) | CASP6TSHRLMNAHCAR3TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-12630844-B2 | Hepatitis E virus-like particles (VLPs) derived from consensus sequences | NOVO CAPSID TECHNOLOGIES LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250236885-A1 | HEPATITIS E VIRUS-LIKE PARTICLES (VLPS) DERIVED FROM CONSENSUS SEQUENCES | NOVO CAPSID TECHNOLOGIES LLC (US) | 2025-07-24 | — | — | US | disclosed |
| WO-2025128404-A2 | HEPATITIS E VIRUS-LIKE PARTICLES (VLPS) DERIVED FROM CONSENSUS SEQUENCES | NOVO CAPSID TECHNOLOGIES LLC (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-119780316-A | Separation method for overcoming plastic interference in soil-soluble organic matter extraction process | 南京师范大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-109503518-B | Substituted biaryl amide compound and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2021-03-30 | — | — | CN | disclosed |
| CN-109503518-A | A kind of substituted double aromatic radical amide compounds and its preparation method and application | 中国医学科学院医药生物技术研究所 | 2019-03-22 | — | — | CN | disclosed |
| CN-103113321-B | 2- (methylthio) benzo [ d ] oxazole-5-carboxylic acid and preparation method thereof | UNIV NANTONG | 2015-02-18 | — | — | CN | disclosed |
| CN-103113321-A | 2- (methylthio) benzo [ d ] oxazole-5-carboxylic acid and preparation method thereof | UNIV NANTONG | 2013-05-22 | — | — | CN | disclosed |
| WO-2005047901-A2 | COMPOSITIONS AND METHODS FOR DETECTION AND ISOLATION PHOSPHORYLATED MOLECULES | MOLECULAR PROBES, INC. (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050014197-A1 | Compositions and methods for detection and isolation of phosphorylated molecules | MOLECULAR PROBES, INC. | 2005-01-20 | — | — | US | disclosed |
| US-20040171034-A1 | Compositions and methods for detection and isolation of phosphorylated molecules | MOLECULAR PROBES, INC. | 2004-09-02 | — | — | US | disclosed |
| WO-2004042347-A2 | COMPOSITIONS AND METHODS FOR DETECTION AND ISOLATION OF PHOSPHORYLATED MOLECULES | MOLECULAR PROBES, INC. (US) | 2004-05-21 | — | — | WO | disclosed |
| US-20040038306-A1 | Compositions and methods for detection and isolation of phosphorylated molecules | MOLECULAR PROBES, INC. | 2004-02-26 | — | — | US | disclosed |
| EP-0882033-B1 | BENZOFURAN-ACRYLIC ACID DERIVATIVES AND THEIR USE AS MODULATORS OF RXRS OR RARS RECEPTORS | CT INTERNAT DE RECH S (FR) | 2001-08-16 | — | — | EP | disclosed |
| EP-0882033-A1 | BENZOFURAN-ACRYLIC ACID DERIVATIVES AND THEIR USE AS MODULATORS OF RXRS OR RARS RECEPTORS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) | 1998-12-09 | — | — | EP | disclosed |
| US-5830999-A | CARBOXYLIC LIGANDS, HEXAMERS | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-11-03 | — | — | US | disclosed |
| WO-1998024778-A1 | BENZOFURAN-ACRYLIC ACID DERIVATIVES AND THEIR USE AS MODULATORS OF RXRS OR RARS RECEPTORS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1998-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630844-B2 | Hepatitis E virus-like particles (VLPs) derived from consensus sequences | HAVCR2, SSU72, CD74 | CASP6 4045/4885TSHR 1289/4885LMNA 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.